Johnson & Johnson

NYSE:JNJ  
159.37
+2.28 (+1.45%)
4:24:59 PM EDT: $159.38 +0.01 (+0.01%)
Earnings Announcements, Mergers / Acquisitions

J&J Says From A Financial Standpoint, Plan To Split Into Two Companies, Is At The "Right Time"

Published: 11/12/2021 14:35 GMT
Johnson & Johnson (JNJ) - :j&j Exec Says New Pharma Division Will Consist 65% of Whole Co's Business- Conf Call.
J&j Exec Says New Consumer Co Has Growth Opportunities and Will Invest and Buy New Business Models - Conf Call.
J&j Says Evolution in Consumer Markets, Shift to E-commerce, Interest in Personal Care During Pandemic Made It "right Time" for New Consumer Co to Form.
J&j on Plan to Separate Says From a Financial Standpoint This "is the Right Time" - Conf Call.
J&j Says Fit and Focus Strategy Will Help Co Hit Long Term Targets - Conf Call.
J&j Says on Deal Synergies Says Cost Will Be Half a Billion to a Billion - Conf Call.
J&j Says on Deal Synergies Analysis is Prelim at This Point - Conf Call.
J&j in Response to Analyst Question on Talc Settlement Says Today's Announcement is Separate From the Talc Liabilities - Conf Call.
Further Company Coverage: Jnjn ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $25.23 Billion
Adjusted EPS is expected to be $2.16

Next Quarter Revenue Guidance is expected to be $23.68 Billion
Next Quarter EPS Guidance is expected to be $2.61

More details on our Analysts Page.